Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (11)

2024

  1. How Does the Burden of Respiratory Syncytial Virus Compare to Influenza in Spanish Adults?

    Influenza and other Respiratory Viruses, Vol. 18, Núm. 6

2023

  1. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  2. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  3. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

    The Lancet Global Health

2022

  1. Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries

    Frontiers in Pediatrics, Vol. 10

2021

  1. A Novel Framework for Phenotyping Children With Suspected or Confirmed Infection for Future Biomarker Studies

    Frontiers in Pediatrics, Vol. 9

2017

  1. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain

    BMC Infectious Diseases, Vol. 17, Núm. 1

2014

  1. Erratun :Prevention of serogroup B meningococcal disease using a four-component vaccine (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013)

    Anales de Pediatria

  2. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

  3. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes

    Pediatria de Atencion Primaria, Vol. 16, Núm. 62

  4. Prevention of serogroup B meningococcal disease using a four-component vaccin

    Anales de Pediatria, Vol. 80, Núm. 4